Synonyms: IAG-933 | NVP-IAG933
Compound class:
Synthetic organic
Comment: IAG933 is a small molecule that inhibits the protein-protein interaction (PPI) between YAP/TAZ and TEAD [1], as a route to inhibit oncogenic activation of the Hippo pathway [2]. IAG933 binds with high-affinity to the TEAD pocket (of all TEAD paralogs) that participates in formation of the YAP/TAZ-TEAD PPI.
|
|
No information available. |
Summary of Clinical Use ![]() |
IAG933 is a clinical candidate for the treatment of mesothelioma, and potentially other solid tumour types. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04857372 | A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors | Phase 1 Interventional | Novartis |